A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment, among individuals ages 5-24 years.
Breakthrough in gene therapy could help protect against heart arrhythmias
Cardiac arrhythmias affect millions across the world and are responsible for a fifth of all deaths in the Netherlands.
February 20, 2025